THE PROGNOSTIC/PREDICTIVE ROLE OF IDH1 GENE MUTATIONS IN PATIENTS TREATED FOR RECURRENT GLIOMA

被引:0
|
作者
Lv, S. [1 ,2 ]
Sadones, J. [1 ,2 ]
Teugels, E. [1 ,2 ]
Huylebrouck, M. [1 ,2 ]
De Witte, O. [3 ]
Salmon, I. [4 ]
Michotte, A. [5 ]
De Greve, J. [1 ,2 ]
Neyns, B. [1 ,2 ]
机构
[1] Vrije Univ Brussel, Mol Oncol Lab, Brussels, Belgium
[2] Vrije Univ Brussel, Dept Med Oncol, UZ Brussel, Brussels, Belgium
[3] ULB Erasme, Dept Neurosurg, Brussels, Belgium
[4] ULB Erasme, Dept Pathol, Brussels, Belgium
[5] Vrije Univ Brussel, Dept Pathol, UZ Brussel, Brussels, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:31 / 32
页数:2
相关论文
共 50 条
  • [1] Correlation between IDH1 Gene Mutation Status and Survival of Patients Treated for Recurrent Glioma
    Lv, Shasha
    Teugels, Erik
    Sadones, Jan
    Quartier, Erik
    Huylebrouck, Mike
    Du Four, Stephanie
    Le Mercier, Marie
    De Witte, Olivier
    Salmon, Isabelle
    Michotte, Alex
    De Greve, Jacques
    Neyns, Bart
    ANTICANCER RESEARCH, 2011, 31 (12) : 4457 - 4463
  • [2] Prognostic Significance of Concurrent Gene Mutations in Intensively Treated Patients with IDH1/2 Mutated AML
    Duchmann, Matthieu
    Micol, Jean-Baptiste
    Duployez, Nicolas
    Raffoux, Emmanuel
    Thomas, Xavier
    Marolleau, Jean-Pierre
    Braun, Thorsten
    Ades, Lionel
    Chantepie, Sylvain
    Lemasle, Emilie
    Berthon, Celine
    Malfuson, Jean Valere
    Pautas, Cecile
    Lambert, Juliette
    Boissel, Nicolas
    Celli-Lebras, Karine
    Caillot, Denis
    Turlure, Pascal
    Vey, Norbert
    Pigneux, Arnaud
    Recher, Christian
    Terre, Christine
    Gardin, Claude
    Itzykson, Raphael
    Preudhomme, Claude
    Dombret, Herve
    De Botton, Stephane
    BLOOD, 2019, 134
  • [3] Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
    Sonoda, Yukihiko
    Kumabe, Toshihiro
    Nakamura, Taigen
    Saito, Ryuta
    Kanamori, Masayuki
    Yamashita, Yoji
    Suzuki, Hiroyoshi
    Tominaga, Teiji
    CANCER SCIENCE, 2009, 100 (10) : 1996 - 1998
  • [4] IDH1 AND IDH2 MUTATIONS PLAY A FUNDAMENTAL ROLE IN GLIOMA DEVELOPMENT
    Yan, Hai
    Parsons, Donald W.
    Jin, Genglin
    Reitman, Zachary J.
    McLendon, Roger
    Reardon, David A.
    Friedman, Allan H.
    Friedman, Henry
    Herndon, James
    Riggins, Gregory J.
    Jones, Sion
    Kinzler, Ken
    Vogelstein, Bert
    Velculescu, Victor
    Rasheed, Ahmed B.
    Kos, Ivan
    Batinic-Haberle, Ines
    Bigner, Darell
    NEURO-ONCOLOGY, 2009, 11 (05) : 608 - 608
  • [5] IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?
    Labussiere, Marianne
    Sanson, Marc
    Idbaih, Ahmed
    Delattre, Jean-Yves
    ONCOLOGIST, 2010, 15 (02): : 196 - 199
  • [6] Metabolism of glioma and IDH1/IDH2 mutations
    Rossetto, M.
    Ciccarino, P.
    Boisselier, B.
    Labussiere, M.
    Sanson, M.
    REVUE NEUROLOGIQUE, 2011, 167 (10) : 699 - 703
  • [7] IDH1 Non-Canonical Mutations and Survival in Patients with Glioma
    Franceschi, Enrico
    De Biase, Dario
    Di Nunno, Vincenzo
    Pession, Annalisa
    Tosoni, Alicia
    Gatto, Lidia
    Tallini, Giovanni
    Visani, Michela
    Lodi, Raffaele
    Bartolini, Stefania
    Brandes, Alba Ariela
    DIAGNOSTICS, 2021, 11 (02)
  • [8] Favorable role of IDH1/2 mutations aided with MGMT promoter gene methylation in the outcome of patients with malignant glioma
    Pandith, Arshad A.
    Qasim, Iqbal
    Baba, Shahid M.
    Koul, Aabid
    Zahoor, Wani
    Afroze, Dil
    Lateef, Adil
    Manzoor, Usma
    Bhat, Ina A.
    Sanadhya, Dheera
    Bhat, Abdul R.
    Ramzan, Altaf U.
    Mohammad, Fozia
    Anwar, Iqra
    FUTURE SCIENCE OA, 2021, 7 (03):
  • [9] THE PROGNOSTIC VALUE OF IDH1 MUTATIONS IN GLIOMAS
    Dahlrot, Rikke H.
    Kristensen, Bjarne W.
    Hansen, Steinbjorn
    NEURO-ONCOLOGY, 2011, 13 : 82 - 83
  • [10] IDH1/IDH2 mutations predict survival in glioma and AML
    Hegi, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S2 - S2